HealthTech | Nigeria
PBR Life Sciences is Transforming healthcare in emerging markets with big data and AI.
What they do:
PBR Life Sciences is transforming healthcare through the strategic application of big data, advanced technology, and Artificial Intelligence (AI) and Machine Learning (ML).
By offering a top-tier data subscription platform, PBR empowers stakeholders to plan more effectively, reduce costs from product expiration, and uncover profitable market opportunities. Their mission also focuses on promoting inclusion and diversity in clinical trials by leveraging comprehensive healthcare data to close gaps in underrepresented patient populations.
Why we Invested:
PBR Life Sciences operates in a niche market as the first-to-market provider of real-world, multi-variate, multi-channel health data offered as a DaaS subscription platform in Sub-Saharan Africa.
They address a critical gap in the African healthcare market by aggregating, standardizing, and analyzing fragmented healthcare data using advanced AI/ML techniques. This approach provides invaluable, actionable insights for the life sciences industry, enabling better decision-making, improved resource allocation, and enhanced patient outcomes.
The Founder:
Ayodeji Alaran Is the Founder and CEO of PBR Life Sciences. He held leadership positions at IQVIA, Cegedim, Pfizer, AstraZeneca, and Johnson & Johnson.
A Techstars ‘23 graduate, Ayodeji holds an MBA from London Business School, Bachelor of Pharmacy from the University of Lagos, and has a proven track record in product development and innovation, sales, marketing, and business development.
Active in:
Nigeria
